$23.51
-0.02-0.08%
At close: -
$23.51
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest Pacira BioSciences Stock News | NASDAQ:PCRX | Benzinga
Get the latest news on Pacira BioSciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Pacira BioSciences performance
Categories: All
Friday, February 28, 2025
Thursday, February 27, 2025
Friday, February 14, 2025
Tuesday, February 11, 2025
Thursday, January 30, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Tuesday, January 07, 2025
Wednesday, December 04, 2024
Tuesday, December 03, 2024
Thursday, November 14, 2024
Tuesday, November 12, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
Tuesday, November 05, 2024
Monday, October 21, 2024
Friday, October 04, 2024
Thursday, October 03, 2024
Thursday, September 26, 2024
Wednesday, September 25, 2024
Tuesday, September 24, 2024
Tuesday, August 13, 2024
Monday, August 12, 2024
- Pain Management-Focused Pacira BioSciences Loses Patent Fight For Key Drug, JP Morgan Analyst Downgrades On Unclear Path
- Where Pacira BioSciences Stands With Analysts
- RBC Capital Downgrades Pacira BioSciences to ...
- JetBlue Airways, B. Riley Financial, Hawaiian Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- HC Wainwright & Co. Maintains Buy on Pacira B...
- Needham Maintains Buy on Pacira BioSciences, ...
- JP Morgan Downgrades Pacira BioSciences to Un...